Persephin signaling through GFRalpha1: the potential for the treatment of Parkinson's disease.

Sidorova, Yulia A; Mätlik, Kert; Paveliev, Mikhail; Lindahl, Maria; Piranen, Elisa; Milbrandt, Jeffrey; Arumäe, Urmas; Saarma, Mart; Bespalov, Maxim M

Sidorova, Yulia A; Mätlik, Kert; Paveliev, Mikhail; Lindahl, Maria; Piranen, Elisa; Milbrandt, Jeffrey; Arumäe, Urmas; Saarma, Mart; Bespalov, Maxim M.

Affiliation

Sidorova YA; Institute of Biotechnology, Viikki Biocenter, University of Helsinki, Helsinki, FIN-00014, Finland.

Mol Cell Neurosci ; 44(3): 223-32, 2010 Jul.

Article in En | MEDLINE | ID: mdl-20350599

Subject(s)

Glial Cell Line-Derived Neurotrophic Factor Receptors/metabolism; Nerve Tissue Proteins/metabolism; Parkinson Disease/therapy; Signal Transduction/physiology; Animals; Biological Assay/methods; Cell Line; Glial Cell Line-Derived Neurotrophic Factor/metabolism; Glial Cell Line-Derived Neurotrophic Factor Receptors/genetics; Humans; Mice; Models, Molecular; Nerve Growth Factors/chemistry; Nerve Growth Factors/genetics; Nerve Growth Factors/metabolism; Nerve Tissue Proteins/genetics; Neurons/physiology; Protein Conformation; Proto-Oncogene Proteins c-ret/genetics; Proto-Oncogene Proteins c-ret/metabolism; Rats; Rats, Wistar

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Signal Transduction / Glial Cell Line-Derived Neurotrophic Factor Receptors / Nerve Tissue Proteins Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2010 Type: Article

Fulltext

XML

PubMed Links

Search on Google